doi: 10.1016/s1286-4579(01)01526-x.
Emil von Behring and serum therapy
Affiliations
- PMID: 11880051
- DOI: 10.1016/s1286-4579(01)01526-x
Item in Clipboard
Emil von Behring and serum therapy
Microbes Infect.
2002 Feb.
Free article
Abstract
Emil von Behring is the father of serum therapy. We present an overview of the development of this important tool in the treatment of diphtheria. In a historical context Behring's work reflects the scientific spirit of fin de siècle Berlin.
Similar articles
-
[Behring's personal papers--Behring's lives].Ber Wiss. 2014 Sep;37(3):216-39. doi: 10.1002/bewi.201401680. Ber Wiss. 2014. PMID: 25296526 German.
-
[Emil von Bering and the development of German immunology].Med Welt. 1979;30(48):1795-801. Med Welt. 1979. PMID: 392221 German. No abstract available.
-
Emil von Behring (1854-1917): Medicine's first Nobel laureate.Singapore Med J. 2011 Jan;52(1):1-2. Singapore Med J. 2011. PMID: 21298232 No abstract available.
-
From the Gorgon's blood to Behring's Blutserumtherapie: A long path towards serum therapy.Immunol Rev. 2024 Nov;328(1):13-23. doi: 10.1111/imr.13391. Epub 2024 Sep 14. Immunol Rev. 2024. PMID: 39276357 Review.
-
A centennial review; the 1890 tetanus antitoxin paper of von Behring and Kitasato and the related developments.Keio J Med. 1991 Mar;40(1):35-9. doi: 10.2302/kjm.40.35. Keio J Med. 1991. PMID: 2046211 Review.
Cited by
-
The Role of Animal Research in Pandemic Responses.Comp Med. 2021 Oct 1;71(5):359-368. doi: 10.30802/AALAS-CM-21-000062. Epub 2021 Oct 5. Comp Med. 2021. PMID: 34610857 Free PMC article.
-
High-Throughput Neutralization and Serology Assays Reveal Correlated but Highly Variable Humoral Immune Responses in a Large Population of Individuals Infected with SARS-CoV-2 in the US between March and August 2020.mBio. 2023 Apr 25;14(2):e0352322. doi: 10.1128/mbio.03523-22. Epub 2023 Feb 14. mBio. 2023. PMID: 36786604 Free PMC article.
-
Single domain antibodies from camelids in the treatment of microbial infections.Front Immunol. 2024 May 17;15:1334829. doi: 10.3389/fimmu.2024.1334829. eCollection 2024. Front Immunol. 2024. PMID: 38827746 Free PMC article. Review.
-
Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global Pandemic.Risk Manag Healthc Policy. 2020 Nov 23;13:2707-2728. doi: 10.2147/RMHP.S281388. eCollection 2020. Risk Manag Healthc Policy. 2020. PMID: 33262668 Free PMC article. Review.
-
SARS-CoV-2 Cellular Infection and Therapeutic Opportunities: Lessons Learned from Ebola Virus.Membranes (Basel). 2021 Jan 18;11(1):64. doi: 10.3390/membranes11010064. Membranes (Basel). 2021. PMID: 33477477 Free PMC article. Review.
Publication types
MeSH terms
Substances
Personal name as subject
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
